Dentists in Camp Lejeune, NC Accepting Medicare
143 Dentists found. Showing 81 - 100
 Mrs. Marina Alissa Hernandez Dentist Medicare: Not Enrolled in Medicare Practice Location: 315 Mchugh Blvd Psc 20130, Commanding Officer, 2d Denbn/ndc, Camp Lejeune, NC 28540 Phone: 910-451-2208 Fax: 910-451-8036 |
 Eli Nathan Lowry, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: Psc 20130 315 Mchugh Blvd, Commanding Officer, 2d Denbn/ndc, Camp Lejeune, NC 28542 Phone: 910-451-2208 Fax: 910-451-8036 |
Stephen Alexander Yamodis, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 2d Dental Battalion, Naval Dental Center, Camp Lejeune, NC 29405 Phone: 910-451-2208 Fax: 910-451-2208 |
Dr. John Norfleet, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 212 Wallace Creek Rd, Camp Lejeune, NC 28547 Phone: 910-451-6122 |
Clare Coons, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 100 Brewster Blvd, Camp Lejeune, NC 28547 Phone: 910-451-1053 |
Dr. Lauren Danielle Gadeberg, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 2d Denbn/ndc, Psc 20130 315 Mchugh Blvd, Commanding Officer, Camp Lejeune, NC 28542 Phone: 910-451-2208 Fax: 910-451-8036 |
Dr. Stuart O Miller, DDS Dentist - Endodontics Medicare: Medicare Enrolled Practice Location: 315 Mchugh Blvd, Camp Lejeune, NC 28547 Phone: 910-451-1013 Fax: 910-451-4194 |
Dr. Matthew Aaron Russell, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 315 Mchugh Blvd, 2d Denbn/ndc, Camp Lejeune, NC 28547 Phone: 910-451-2208 Fax: 910-451-8036 |
Dr. Tuanh Carson Halquist, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 315 Mchugh Blvd, 2d Dental Battalion/naval Dental Center, Camp Lejeune, NC 28547 Phone: 252-466-0401 |
Dr. Blake Aaron Donaldson, DDS Dentist - Endodontics Medicare: Not Enrolled in Medicare Practice Location: 315 Mchugh Blvd, Commanding Officer 2d Denbn/ndc Psc 20130, Camp Lejeune, NC 28540 Phone: 910-451-2208 Fax: 910-451-8036 |
Marissa T Singh, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: Commanding Officer, 2d Denbn/ndc, Psc 20130 315 Mchugh Blvd, Camp Lejeune, NC 28542 Phone: 910-451-2208 Fax: 910-451-8479 |
Dr. Jaren Thomas May, D.D.S., M.S.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: Bldg Hp-102, 700 Mchugh Blvd, Camp Lejeune, NC 28547 Phone: 910-451-1658 |
Dr. David P. Maciborski, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 100 Brewster Blvd, Camp Lejeune, NC 28547 Phone: 910-450-4740 Fax: 910-450-4452 |
Tyler Avery Oakes, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 700 Mchugh Blvd, Bldg Hp 102, Camp Lejeune, NC 28547 Phone: 910-450-4740 |
Dr. William Claude Beutel, DDS Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 100 Brewster Blvd, Naval Hospital Camp Lejeune, Camp Lejeune, NC 28547 Phone: 910-450-4136 Fax: 910-450-4558 |
Robert Etheridge, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 315 Mchugh Blvd, 2d Denbn/ndc, Camp Lejeune, NC 28547 Phone: 910-451-2208 Fax: 910-451-8036 |
Dr. Clifford Dean Luttrell Jr., DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2d Denbn/ndc, Psc 20130, Camp Lejeune, NC 28542 Phone: 252-466-0400 |
Dr. Dennis Gregory Sampson, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 315 Mchugh Blvd, 2d Dental Battalion/ Naval Dental Center, Camp Lejeune, NC 28547 Phone: 910-451-2208 Fax: 910-451-8036 |
Dr. Clifford William Moore, DDS Dentist Medicare: Medicare Enrolled Practice Location: 315 Mchugh Blvd 2d Denbn/ndc, Commanding Officer, Camp Lejeune, NC 28540 Phone: 910-451-2208 Fax: 910-451-8036 |
Dr. Sung Woo Kim, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 212 Wallace Creek Rd, Camp Lejeune, NC 28547 Phone: 910-451-6122 |
News Archive
Researchers determine function of new IKKα enzyme variant in colorectal cancer
Researchers from IMIM, Hospital del Mar Medical Research Institute, have succeeded in determining the function of a new variant of enzyme IKKalpha (IKKα) to activate some of the genes taking part in the tumor progressions of colorectal cancer.
New study following 12,574 individuals over the course of three years of HAART
Although clinical progression to AIDS of patients infected with Human immunodeficiency virus (HIV) has declined since the introduction of Highly Active Antiretroviral Therapy (HAART), there is little data on the changes in incidence of AIDS-defining events during the first few years of therapy.
Silicon Valley using health care perks to lure talent
High salaries and free food aren't enough any more in Silicon Valley, where maturing companies are competing for talent with creative health care and "wellness" programs that use gadgets to promote good behavior. Standard benefits at the largest technology companies, including Google Inc and Apple Inc, range from fertility treatments to deluxe on-site medical clinics, to new technology treats like health-tracking bracelets. The health largesse separates Silicon Valley's raging economy from many other sectors in the United States, but tech companies' experiments with perks show signs of spreading, benefits managers say.
NASDAQ Panel grants NexMed extension to meet remaining listing requirements
NexMed, Inc., a specialty CRO and a developer of products based on the NexACT technology, today announced that the NASDAQ Listing Qualifications Panel (the "Panel") has determined that NexMed has evidenced compliance with the market value of listed securities requirement for continued listing on The NASDAQ Capital Market by evidencing a market capitalization in excess of $35 million for a minimum of ten consecutive trading days, in lieu of the $2.5 million in stockholder's equity as required by the Panel's decision dated December 17, 2009.
4SC commences treatment in its resminostat Phase II trial for HL
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, today announced the treatment of the first patient in a Phase II study evaluating resminostat (4SC-201), an oral pan-histone-deacetylase (HDAC) inhibitor in relapsed or refractory Hodgkin's Lymphoma (HL) patients.
› Verified 4 days ago
Dentists
Pharmacists
Clinical Social Workers
Psychologists
Occupational Therapists